These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26101276)

  • 21. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana.
    Mockenhaupt FP; Bedu-Addo G; Eggelte TA; Hommerich L; Holmberg V; von Oertzen C; Bienzle U
    J Infect Dis; 2008 Nov; 198(10):1545-9. PubMed ID: 18834303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimalarials during pregnancy: a cost-effectiveness analysis.
    Schultz LJ; Steketee RW; Chitsulo L; Wirima JJ
    Bull World Health Organ; 1995; 73(2):207-14. PubMed ID: 7743592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to chondroitin sulfate A-binding infected erythrocytes: dynamics and protection during pregnancy in women receiving intermittent preventive treatment.
    Aitken EH; Mbewe B; Luntamo M; Maleta K; Kulmala T; Friso MJ; Fowkes FJ; Beeson JG; Ashorn P; Rogerson SJ
    J Infect Dis; 2010 May; 201(9):1316-25. PubMed ID: 20350189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan.
    Adam I; Ali DM; Abdalla MA
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):632-5. PubMed ID: 16436287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.
    Crawley J; Hill J; Yartey J; Robalo M; Serufilira A; Ba-Nguz A; Roman E; Palmer A; Asamoa K; Steketee R
    Lancet Infect Dis; 2007 Feb; 7(2):145-55. PubMed ID: 17251085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortisol, prolactin, cytokines and the susceptibility of pregnant Sudanese women to Plasmodium falciparum malaria.
    Bayoumi NK; Elhassan EM; Elbashir MI; Adam I
    Ann Trop Med Parasitol; 2009 Mar; 103(2):111-7. PubMed ID: 19208295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.
    Eisele TP; Larsen DA; Anglewicz PA; Keating J; Yukich J; Bennett A; Hutchinson P; Steketee RW
    Lancet Infect Dis; 2012 Dec; 12(12):942-9. PubMed ID: 22995852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative cytokine level of TNF-α, IFN-γ, IL-10, TGF-β and circulating Epstein-Barr virus DNA load in individuals with acute Malaria due to P. falciparum or P. vivax or double infection in a Malaria endemic region in Indonesia.
    Budiningsih I; Dachlan YP; Hadi U; Middeldorp JM
    PLoS One; 2021; 16(12):e0261923. PubMed ID: 34962938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda.
    Braun V; Rempis E; Schnack A; Decker S; Rubaihayo J; Tumwesigye NM; Theuring S; Harms G; Busingye P; Mockenhaupt FP
    Malar J; 2015 Sep; 14():372. PubMed ID: 26410081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Profile of cytokines associated with protection against malaria episodes during pregnancy in hypo-endemic area in Senegal].
    Ndiaye M; Ndiaye JL; Tine R; Sylla K; Faye B; Diouf I; Sow D; Lo AC; Abiola A; Dieng Y; Gaye O
    Bull Soc Pathol Exot; 2014 Aug; 107(3):159-64. PubMed ID: 24842755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proinflammatory responses and higher IL-10 production by T cells correlate with protection against malaria during pregnancy and delivery outcomes.
    Requena P; Barrios D; Robinson LJ; Samol P; Umbers AJ; Wangnapi R; Ome-Kaius M; Rosanas-Urgell A; Mayor A; López M; de Lazzari E; Arévalo-Herrera M; Fernández-Becerra C; del Portillo H; Chitnis CE; Siba PM; Rogerson S; Mueller I; Bardají A; Menéndez C; Dobaño C
    J Immunol; 2015 Apr; 194(7):3275-85. PubMed ID: 25725110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity to placental malaria. II. Placental antigen-specific cytokine responses are impaired in human immunodeficiency virus-infected women.
    Moore JM; Ayisi J; Nahlen BL; Misore A; Lal AA; Udhayakumar V
    J Infect Dis; 2000 Sep; 182(3):960-4. PubMed ID: 10950798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Dorman EK; Kawuondo K; Marsh K; Hviid L
    Infect Immun; 2004 Sep; 72(9):5027-30. PubMed ID: 15321995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
    Mockenhaupt FP; Bedu-Addo G; Junge C; Hommerich L; Eggelte TA; Bienzle U
    Antimicrob Agents Chemother; 2007 Jan; 51(1):332-4. PubMed ID: 17088491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
    Selimova LM; Kalnina LB; Serebrovskaya LV; Ivanova LA; Gulyaeva AN; Nosik DN
    Vopr Virusol; 2016; 61(1):39-41. PubMed ID: 27145600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.